Latest News and Press Releases
Want to stay updated on the latest news?
-
Selbyville, Delaware, Nov. 09, 2022 (GLOBE NEWSWIRE) -- The ambulatory surgical centers market value is estimated to exceed USD 144.5 billion by 2032, according to a new research report by Global...
-
PLATTSBURGH, N.Y., June 16, 2022 (GLOBE NEWSWIRE) -- NasoNeb®, Inc. is proud to announce their integration with Monaghan Medical Corporation (“Monaghan Medical”) in Plattsburgh, New York. Monaghan...
-
SAN DIEGO, Feb. 25, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that...
-
SAN DIEGO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced...
-
PLATTSBURGH, N.Y., Oct. 28, 2021 (GLOBE NEWSWIRE) -- NasoNeb, Inc. (the “Company” or “NasoNeb”), a developer of innovative intranasal drug delivery and nasal care solutions, is proud to welcome Dr....
-
Selbyville, Delaware, Oct. 04, 2021 (GLOBE NEWSWIRE) -- The ambulatory surgical centers market size is anticipated to record a valuation of USD 117 billion by 2027, according to the most recent...
-
SAN DIEGO, Sept. 27, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the...
-
SAN DIEGO, April 05, 2021 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the...
-
SAN DIEGO, Feb. 06, 2019 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced...
-
SAN DIEGO, Oct. 30, 2018 (GLOBE NEWSWIRE) -- Otonomy, Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for otology, today announced multiple...